Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 7(6): e40069, 2012.
Article in English | MEDLINE | ID: mdl-22768222

ABSTRACT

Pathogen-activated and damage-associated molecular patterns activate the inflammasome in macrophages. We report that mouse macrophages release IL-1ß while co-incubated with pro-B (Ba/F3) cells dying, as a result of IL-3 withdrawal, by apoptosis with autophagy, but not when they are co-incubated with living, apoptotic, necrotic or necrostatin-1 treated cells. NALP3-deficient macrophages display reduced IL-1ß secretion, which is also inhibited in macrophages deficient in caspase-1 or pre-treated with its inhibitor. This finding demonstrates that the inflammasome is activated during phagocytosis of dying autophagic cells. We show that activation of NALP3 depends on phagocytosis of dying cells, ATP release through pannexin-1 channels of dying autophagic cells, P(2)X(7) purinergic receptor activation, and on consequent potassium efflux. Dying autophagic Ba/F3 cells injected intraperitoneally in mice recruit neutrophils and thereby induce acute inflammation. These findings demonstrate that NALP3 performs key upstream functions in inflammasome activation in mouse macrophages engulfing dying autophagic cells, and that these functions lead to pro-inflammatory responses.


Subject(s)
Adenosine Triphosphate/metabolism , Autophagy , Inflammasomes/metabolism , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/pathology , Phagocytosis , Animals , Apoptosis/drug effects , Autophagy/drug effects , Carrier Proteins/metabolism , Caspase 1/metabolism , Cell Line , Imidazoles/pharmacology , Indoles/pharmacology , Inflammation/pathology , Injections, Intraperitoneal , Interleukin-1beta/metabolism , Interleukin-3/deficiency , Interleukin-6/metabolism , Lipopolysaccharides/pharmacology , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/enzymology , Mice , Mice, Inbred C57BL , NLR Family, Pyrin Domain-Containing 3 Protein , Necrosis , Neutrophil Infiltration/drug effects , Peritoneal Cavity/pathology , Phagocytosis/drug effects , Thioglycolates
2.
Autophagy ; 7(3): 321-30, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21217200

ABSTRACT

Phagocytosis of naturally dying cells usually blocks inflammatory reactions in host cells. We have recently observed that clearance of cells dying through autophagy leads to a pro-inflammatory response in human macrophages. Investigating this response further, we found that during engulfment of MCF-7 or 293T cells undergoing autophagic death, but not apoptotic or anoikic ones, caspase-1 was activated and IL-1ß was processed, then secreted in a MyD88-independent manner. Autophagic dying cells were capable of preventing some LPS-induced pro-inflammatory responses, such as TNFα, IL-6 and IL-8 induction, but synergized with LPS for IL-1ß production. Caspase-1 inhibition prevented macrophage IL-1ß release triggered by the dying cells and also other pro-inflammatory cytokines which were not formed in the presence of IL-1 receptor antagonist anakinra either. IL-1ß secretion was also observed using calreticulin knock down or necrostatin treated autophagic MCF-7 cells and it required phagocytosis of the dying cells which led to ATP secretion from macrophages. Blocking K (+) efflux during phagocytosis, the presence of apyrase, adding an antagonist of the P2X7 receptor or silencing the NOD-like receptor protein NALP3 inhibited IL-1ß secretion. These data suggest that during phagocytosis of autophagic dying cells ATP, acting through its receptor, initiates K (+) efflux, inflammasome activation and secretion of IL-1ß, which initiates further pro-inflammatory events. Thus, autophagic death of malignant cells and their clearance may lead to immunogenic response.


Subject(s)
Autophagy , Inflammasomes/metabolism , Interleukin-1beta/metabolism , Macrophages/cytology , Macrophages/metabolism , Adenosine Triphosphate/metabolism , Autophagy/drug effects , Cell Line, Tumor , Humans , Inflammation Mediators/metabolism , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Myeloid Differentiation Factor 88/metabolism , Receptors, Purinergic P2X7/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...